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ABSTRACT
Single nucleotide polymorphisms (SNPs) are an
increasingly important tool for genetic and biomedi-
cal research. However, the accumulated sequence
information on allelic variation is not matched by an
understanding oftheeffectofSNPson thefunctional
attributes or ‘molecular phenotype’ of a protein.
Towards this aim we developed SNPeffect, an online
resource of human non-synonymous coding SNPs
(nsSNPs) mapping phenotypic effects of allelic vari-
ation in human genes. SNPeffect contains 31659
nsSNPs from 12480 human proteins. The current
release of SNPeffect incorporates data on protein
stability, integrity of functional sites, protein phos-
phorylation and glycosylation, subcellular localiza-
tion, protein turnover rates, protein aggregation,
amyloidosis and chaperone interaction. The SNP
entries are accessible through both a search and
browse interface and are linked to most major
biological databases. The data can be displayed as
detailed descriptions of individual SNPs or as an
overview of all SNPs for a given protein. SNPeffect
will be regularly updated and can be accessed at
http://snpeffect.vib.be/.
INTRODUCTION
As a result of the ongoing genomic efforts worldwide an
enormous amount of sequence information on human DNA
variation is accumulating (1). Single nucleotide polymorph-
isms (SNPs) are the most common form of allelic variation
observed in human populations. NCBI’s dbSNP (1) currently
contains 4540241 validated human entries out of which
45896 are non-synonymous coding SNPs (nsSNPs). Although
only 1–3% of the human genome is taken up by protein-coding
regions, this small subset of coding SNPs (together with SNPs
in gene regulatory regions) has the highest likelihood of being
functionally relevant. Most of what is known about the gen-
etics of diseases comes either from studies on rare monogen-
etic diseases or from family studies of common diseases that
have identiﬁed rare high-risk variants. However, modest-risk
variantsprobablyhaveahigherimpactonpublichealthbecause
they have a higher frequency in human populations than much
less frequent but high-risk variants [the so-called common
disease-common variant hypothesis (2)]. For instance, only
5% of all Alzheimer’s cases can be attributed to more than
150 rare high-risk alleles (3) whereas the presence of the
Apoe allele in late-onset Alzheimer’s has been estimated to
be 20% (4). The availability of SNPs offers the possibility
to develop high-density genetic maps for whole-genome
association analyses, allowing the identiﬁcation of genetic
polymorphisms contributing to susceptibility for common
polygenetic diseases. If we aim at truly linking genetic vari-
ation with phenotypic variation and natural selection a ﬁrst
step will be to describe how allelic variation affects the func-
tional attributes or molecular phenotype of a protein (5). The
effect of many nsSNPs will probably be neutral as natural
selection will have removed mutations on essential positions.
However, a fraction of nsSNPs will display phenotypic varia-
tion at the molecular level that will, by interaction with other
proteins, affect intermediate phenotypes relevant from a clin-
ical viewpoint [for instance, low-density lipoprotein (LDL)
levels for risk assessment of myocardial infarction]. Assess-
ment of non-neutral SNPs is mainly based on phylogenetic
information (i.e. correlation with residue conservation)
extended to a certain degree with structural approaches [e.g.
see PolyPhen (6) and the method of Chasman and Adams (7)].
Here we present SNPeffect, a web-server describing the
effect of nsSNPs on the molecular phenotype of human pro-
teins. Our goal is to assign the effect of SNPs to speciﬁc
functional attributes. For each protein in which SNPs are
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doi:10.1093/nar/gki086mapped, we compare their effect on protein stability and
folding, aggregation and amyloidosis, catalytic sites and bind-
ing sites, phosphorylation and glycosylation sites, cellular
localization and protein turnover.
MOLECULAR PHENOTYPING OF ALLELIC
VARIANTS
SNPeffect uses not only in-house but also other publicly
availablebiocomputationaltoolstopredicttheeffectofnsSNPs
on functional properties deﬁning the molecular phenotype of
proteins. The functional properties evaluated in the current
releaseofSNPeffectareclassiﬁedintothreecategories:(i)pro-
perties affecting protein folding and stability, (ii) properties
affecting functional sites and binding sites and (iii) properties
affecting cellular processing of a protein. The results belong-
ing to each of these categories can be accessed in a summar-
ized way in the protein-centred view or can be looked up in
detail for each SNP in the SNP-centred view. Easy toggling
between both views is provided.
Protein folding and stability
Whenever a high-quality structure (better than 3 s)i s
available, the mutation is modelled and its energetic effect is
evaluated with the FoldX force ﬁeld (8). The FoldX force ﬁeld
was developed for the fast and accurate estimation of the free
change upon mutation on the stability of a protein or a protein
complex. FoldX has been validated on a test database of more
than 1000 mutants from more than 20 different proteins.
FoldX currently yields a correlation of 0.78 with a SD of
0.41 kcal/mol. Changes in protein aggregation and amyloidosis
are evaluated with the algorithms TANGO (9) and AmyScan
(10,11), respectively. TANGO is a statistical mechanics algo-
rithm that identiﬁes the regions of a protein sequence involved
in the process of b-sheet aggregation. TANGO was validated
onasetof250peptides.AmyScanscansaproteinsequence for
six-residueamyloidogenicstretches.Amyloidfragmentidenti-
ﬁcation relies on a sequence pattern extracted from a satura-
tion mutagenesis analysis on a de novo designed amyloid
peptide and has been validated experimentally. In addition,
PROF (12,13) was used to predict secondary structure, solvent
accessibility and transmembrane regions.
Functional sites
Integrity of active sites is checked for all enzymes having an
entryinthe CSA database (14). The CatalyticSite Atlas (CSA)
is a database documenting enzyme active sites and catalytic
residues in enzymes for which three-dimensional structures
are available. The authors deﬁned a classiﬁcation of catalytic
residues, which includes only those residues thought to be
directly involved in some aspect of the reaction catalysed by
an enzyme. The CSA contains two types of entries: (i) original
hand-annotated entries, derived from the primary literature and
(ii) homologous entries, found by PSI-BLAST alignment (using
an E-value cut-off of 0.00005) to one of the original entries.
The equivalent residues, which align in sequence to the
catalytic residues found in the original entry are documented.
To further analyse functional sites, we are currently in the
process of mapping disruption in protein–protein interaction
sites using the FoldX force ﬁeld described above.
Cellular processing
Two tools are used to predict subcellular localization: PA
Subcellular and Psort II. PA Subcellular uses established
machine learning techniques to predict the localization of
the protein, namely, mitochondrion, nucleus, endoplasmic
reticulum, extracellular, cytoplasm, plasma membrane,
Golgi, lysosome or peroxisome. Rather than using sequence
information alone, this method uses database text annota-
tions from homologues and machine learning to substan-
tially improve the prediction of subcellular location. The
authors report an accuracy of 92–94% (15). Psort II uses
a k-nearest neighbour classiﬁer that is trained on yeast
sequences from Swiss-Prot (16). The subcellular localiza-
tions that can be predicted are cytoskeletal, cytoplasmic,
nuclear, mitochondrial, vesicles of secretory system, endo-
plasmic reticulum, Golgi, vacuolar, plasma membrane, per-
oxisomal and extracellular localizations including the cell
wall. Effects on post-translational modiﬁcation sites are also
screened: phosphorylation is checked with PhosphoBase
(17) and glycosylation with O-Glycobase (18). PhosphoBase
contains information about phosphorylated residues in
proteins and data about peptide phosphorylation by a variety
of protein kinases. The data are collected from literature and
compiled into a common format. PhosphoBase covers
phosphorylatable serine, threonine and tyrosine residues.
O-GLYCBASE is a database of glycoproteins with O-linked
glycosylation sites. Entries with at least one experimentally
veriﬁed O-glycosylation site have been compiled from
protein sequence databases and literature. Finally, protein
turnover rates depend strongly on the identity of the N-
terminal residue. A highly destabilizing N-terminal residue
such as arginine can lead to a half-life as short as 2 min,
whereas other amino acids produce half-lives of around a
day. We predict protein turnover rates using the N-terminal
rules as described by Varshavsky and coworkers (19,20).
RESULTS AND DISCUSSION
The current version of SNPeffect contains 31659 entries. As
shown in Table 1 most of these SNPs are neutral, producing
no change of molecular phenotype (e.g. only 0.01% of
nsSNPs cause a change in subcellular localization; Figure 1
and Table 1). This is to be expected since large changes in
molecular phenotype such as cellular localization, turnover-
rate or disruption of active sites are very likely to be dele-
terious and will be eliminated by natural selection. When-
ever they are present, however, they form interesting targets
of investigation since they could be associated with disease.
The only molecular phenotype that is signiﬁcantly affected
in more than 50% of the cases analysed is the stability of
the protein. Even if, due to a lack of structural information,
the set of SNPs analysed for stability is very small, it is to
be expected that this trend will be maintained. Change in
stability of a protein is not necessarily deleterious for pro-
tein function and is much more likely to create a more
subtle range of functional effects by modulating protein–
protein interactions. To supplement the lack of structural
information, we are currently generating high-quality homol-
ogy models using the FoldX force ﬁeld.
D528 Nucleic Acids Research, 2005, Vol. 33, Database issueFigure 1. Examples of disruptive effects caused by allelic variation. From the 31659 SNPs analysed by PA Subcellular, 290 show a clear change in subcellular
localization. Arrows signify differences in localization between wild type (WT) and SNP. The label of each arrow shows how many times the transition from one
classification to another occurs in the SNPeffect dataset.
Table 1. Number of differences between wild type (WT) and SNP per property analysed in SNPeffect
Phenotypic property Number of SNPs analysed Number of SNPs with
significant change
Percentage of SNPs with
significant change
Aggregation—TANGO 30738
a 907 2.95
Amylogenic regions—
AmyScan
31659 (of which 28693
had amylogenic regions)
897 2.83
Stability—FoldX 93
b 52 55.91
Subcellular localization—
PA Subcellular
31659 290 0.92
Turnover-rate 31659 28 0.09
Phosphorylation sites—
PhosphoBase
18214
c 2 0.01
Glycosylation sites—
O-GlycBase
18214
c 00
Active sites—CSA 2101
d 00
Hsp70 binding 31659 (of which 20376
had Hsp70 binding regions)
399 1.3
aThe remaining 921 SNP entries caused a runtime error in the TANGO execution.
bOnlyhigh-resolutionPDBstructureswereusedtopredictstabilitychangesfortheSNPs.Thisnumberwillincreaseinthefutureaswewillcontinueby
using models for the FoldX prediction.
cQuerying the PhospoBase and O-GLYCBASE was limited by a non-complete mapping between RefSeq and Swiss-Prot identifiers.
dOnly the SNPs with PDB identifiers could be used to query the CSA.
Nucleic Acids Research, 2005, Vol. 33, Database issue D529Figure 2. From protein centred to SNP centred view. SNPeffect can be searchedfor proteins or for SNPs. In the protein centred view (background) an overview is
given of all known nsSNPs for a given protein as well as of all phenotypic effects of those SNPs on the function of the wild type. By clicking on a particular SNP a
detailed description of the phenotypic effects and the general information of that variant is displayed in six tabs (foreground).
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SNPeffect can be accessed at http://snpeffect.vib.be/. Both a
search and a browse interface are offered, which give the
option to look for SNPs or for proteins; this leads either to a
SNP-centred view or a protein-centred view, respectively
(Figure 2). The SNP view reports all the information of
one speciﬁc SNP in tabs according to the classiﬁcation of
functional properties described earlier. These tabs include a
graphical as well as detailed numerical overview of the
different phenotypic effects, as well as a link to the proper-
ties of the wild type. The data can be displayed as detailed
descriptions of individual SNPs or as an overview of all
SNPs for a given protein. Summaries of phenotypic proper-
ties are given at the ﬁrst tab of the SNP-centred view and
the ‘SNPs’ tab of the protein centred view. The meaning of
output values and scores for the various properties and how
they are translated to ‘signiﬁcant change’ ﬂags is described
in the manual section of the website and in the Supplemen-
tary Materials of this paper.
Search interface
The search interface allows searching for various
identiﬁers (DB cross-references), full-text search in the
protein description. Filters for proteins with structure (PDB
ﬁle) or disease-related proteins can be applied to the search
result.
Browse interface
Through this interface the possibility to browse enzyme codes,
Protein Data Bank (PDB) entries, OMIM entries and Swiss-
Prot accession codes is provided. After choosing a browse
category a speciﬁc entry can be clicked on and a list of
SNPs or proteins for that entry are shown. The same ﬁlters
as in the search interface can be applied.
DATA SOURCES AND LINKS
The raw data source for SNPeffect is NCBI’s dbSNP (1).
From dbSNP nsSNPs were extracted, whereas related pro-
tein entries where extracted from the NCBI Protein
resources. These NCBI accessions (rs for SNP entries and
RefSeq for protein entries) are the key identiﬁers in the
SNPeffect database. Where available protein structures
were retrieved from the PDB (21). For accurate prediction
only crystal structures with a resolution better than 3 s were
selected; NMR structures and low-resolution crystal struc-
tures were rejected. The protein entries were also checked
with two protein indexes, EBI’s International Protein Index
(22) and PDBSprotEC (23), to maximize cross-references
between the different biological databases. Proteins for
which no cross-reference was available in these indexes,
were blasted against the Swiss-Prot database (24) to obtain
the Swiss-Prot accession number where possible. SNPeffect
entries are linked to several important biological databases
including OMIM (25), Gene Ontology (26), the Brenda
Enzyme database (27), Swiss-Prot/TREMBL (24), Pfam
(28) and structural databases such as SCOP (29), CATH
(30), CSA (31) and PDBSUM (32).
DATABASE STATUS AND FUTURE WORK
Currently SNPeffect contains data on 31659 human nsSNPs.
Future work will aim at including high-quality homology
modelsgeneratedusingFoldXtoincreasethestructuralinforma-
tion available in SNPeffect. The list of properties analysed is
continually being extended and will soon include protein fold-
ing and dynamics, metal ion binding, protein–protein interac-
tions and protein–DNA interactions. Subsequently, we will
also create a murine SNPeffect database. The database will
be regularly updated as new SNP data and information on
phenotypic effects become available.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
ACKNOWLEDGEMENTS
We are grateful to Dr Manuela Lopez de la Paz for pre-
publication use of AmyScan. We would also like to thank
Luc Van Wiemeersch and Els Herregods for help with setting
up the computing facilities.
REFERENCES
1. Thorisson,G.A. and Stein,L.D. (2003) The SNP Consortium website:
past, present and future. Nucleic Acids Res., 31, 124–127.
2. Reich,D.E. and Lander,E.S. (2001) On the allelic spectrum of human
disease. Trends Genet., 17, 502–510.
3. Rocchi,A., Pellegrini,S.,Siciliano,G.andMurri,L.(2003) Causativeand
susceptibility genes for Alzheimer’s disease: a review. Brain Res. Bull.,
61, 1–24.
4. Slooter,A.J., van Duijn,C.M., Bots,M.L., Ott,A., Breteler,M.B., De
Voecht,J., Wehnert,A., de Knijff,P., Havekes,L.M., Grobbee,D.E. et al.
(1998) Apolipoprotein E genotype, atherosclerosis, and cognitive
decline: the Rotterdam study. J. Neural Transm. Suppl., 53, 17–29.
5. Bork,P., Jensen,L.J., von Mering,C., Ramani,A.K., Lee,I. and
Marcotte,E.M.(2004)Proteininteractionnetworksfromyeasttohuman.
Curr. Opin. Struct. Biol., 14, 292–299.
6. Ramensky,V., Bork,P. and Sunyaev,S. (2002) Human non-synonymous
SNPs: server and survey. Nucleic Acids Res., 30, 3894–3900.
7. Chasman,D. and Adams,R.M. (2001) Predicting the functional
consequences of non-synonymous single nucleotide polymorphisms:
structure-based assessment of amino acid variation. J. Mol. Biol.,
307, 683–706.
8. Guerois,R., Nielsen,J.E. and Serrano,L. (2002) Predicting changes
in the stability of proteins and protein complexes: a study of more than
1000 mutations. J. Mol. Biol., 320, 369–387.
9. Escamilla-Fernandez,A.M., Rousseau,F., Schymkowitz,J.W. and
Serrano,L. (2004) Prediction of sequence-dependent and mutational
effects on the aggregation of peptides and proteins. Nat. Biotechnol.,
22, 1302–1306.
10. de la Paz,M.L.andSerrano,L.(2004)Sequence determinantsof amyloid
fibril formation. Proc. Natl Acad. Sci. USA, 101, 87–92.
11. Lopez De La Paz,M., Goldie,K., Zurdo,J., Lacroix,E., Dobson,C.M.,
Hoenger,A. and Serrano,L. (2002) De novo designed peptide-based
amyloid fibrils. Proc. Natl Acad. Sci. USA, 99, 16052–16057.
12. Rost,B., Fariselli,P. and Casadio,R. (1996) Topology prediction for
helical transmembrane proteins at 86% accuracy. Protein Sci., 5,
1704–1718.
13. Rost,B. and Sander,C. (1993) Prediction of protein secondary structure
at better than 70-percent accuracy. J. Mol. Biol., 232, 584–599.
14. Porter,C.T., Bartlett,G.J. and Thornton,J.M. (2004) The Catalytic Site
Atlas: a resource of catalytic sites and residues identified in enzymes
using structural data. Nucleic Acids Res., 32, D129–D133.
Nucleic Acids Research, 2005, Vol. 33, Database issue D53115. Lu,Z., Szafron,D., Greiner,R., Lu,P., Wishart,D.S., Poulin,B., Anvik,J.,
Macdonell,C.andEisner,R.(2004)Predictingsubcellularlocalizationof
proteinsusingmachine-learnedclassifiers.Bioinformatics,20,547–556.
16. Nakai,K. and Horton,P. (1999) PSORT: a program for detecting
sorting signals in proteins and predicting their subcellular localization.
Trends Biochem. Sci., 24, 34–35.
17. Kreegipuu,A., Blom,N. and Brunak,S. (1999) PhosphoBase, a
database of phosphorylation sites: release 2.0. Nucleic Acids Res., 27,
237–239.
18. Gupta,R., Birch,H., Rapacki,K., Brunak,S. and Hansen,J. (1999)
O-GLYCBASE version 4.0: a revised database of O-glycosylated
proteins. Nucleic Acids Res., 27, 370–372.
19. Gonda,D.K., Bachmair,A., Wunning,I., Tobias,J.W., Lane,W.S. and
Varshavsky,A. (1989) Universality and structure of the N-end rule.
J. Biol. Chem., 264, 16700–16712.
20. Bachmair,A., Finley,D. and Varshavsky,A. (1986) In vivo half-life
of a protein is a function of its amino-terminal residue. Science, 234,
179–186.
21. Bourne,P.E., Westbrook,J.D., Berman,H.M., Gilliland,G.L.,
Flippen-Anderson,J.L.andTeam,P.(2003)TheProteinDataBank(PDB)
as a research tool. Abstr. Pap. Am. Chem. Soc., 226, U302–U302.
22. Kersey,P., Duarte,J., Williams,A., Karavidopoulou,Y., Birney,E. and
Apweiler,R. (2004) The International Protein Index: an integrated
database for proteomics experiments. Proteomics, 4, 1985–1988.
23. Martin,A.C.R. (2004) PDBSprotEC: a web-accessible database linking
PDB chains to EC numbers via SwissProt. Bioinformatics, 20, 986–988.
24. Boeckmann,B., Bairoch,A., Apweiler,R., Blatter,M.C., Estreicher,A.,
Gasteiger,E., Martin,M.J., Michoud,K., O’Donovan,C., Phan,I. et al.
(2003) The SWISS-PROT protein knowledgebase and its supplement
TrEMBL in 2003. Nucleic Acids Res., 31, 365–370.
25. Hamosh,A., Scott,A.F., Amberger,J., Bocchini,C., Valle,D. and
McKusick,V.A. (2002) Online Mendelian Inheritance in Man (OMIM),
a knowledgebase of human genes and genetic disorders. Nucleic Acids
Res., 30, 52–55.
26. Harris,M.A., Clark,J., Ireland,A., Lomax,J., Ashburner,M.,
Foulger,R., Eilbeck,K., Lewis,S., Marshall,B., Mungall,C.
et al. (2004) The Gene Ontology (GO) database and
informatics resource. Nucleic Acids Res., 32, D258–D261.
27. Schomburg,I.,Chang,A.,Ebeling,C.,Gremse,M.,Heldt,C.,Huhn,G.and
Schomburg,D. (2004) BRENDA, the enzyme database: updates and
major new developments. Nucleic Acids Res., 32, D431–D433.
28. Bateman,A., Coin,L., Durbin,R., Finn,R.D., Hollich,V.,
Griffiths-Jones,S., Khanna,A., Marshall,M., Moxon,S.,
Sonnhammer,E.L. et al. (2004) The Pfam protein families
database. Nucleic Acids Res., 32, D138–D141.
29. Andreeva,A., Howorth,D., Brenner,S.E., Hubbard,T.J., Chothia,C. and
Murzin,A.G. (2004) SCOP database in 2004: refinements integrate
structureandsequencefamily data. NucleicAcidsRes., 32, D226–D229.
30. Orengo,C.A., Pearl,F.M. and Thornton,J.M. (2003) The CATH
domain structure database. Methods Biochem. Anal.,
44, 249–271.
31. Bartlett,G.J., Porter,C.T., Borkakoti,N. and Thornton,J.M. (2002)
Analysis of catalytic residues in enzyme active sites. J. Mol. Biol.,
324, 105–121.
32. Laskowski,R. (2001) PDBsum: summaries and analyses of PDB
structures. Nucleic Acids Res., 29, 221–222.
D532 Nucleic Acids Research, 2005, Vol. 33, Database issue